Ocrelizumab: Solution concentrate for I.V. infusion 300 mg in 10 mL; Ocrevus® Page last updated: 16 March 2018 Public Summary Document (PSD) November 2017 PBAC Meeting - (PDF 135 KB) Public Summary Document (PSD) November 2017 PBAC Meeting - (Word 42 KB)